InvestSMART

Invion Limited (ASX: IVX) - Announcements

- Current share price for IVX : $0.035

ASX company news and announcements for Invion Limited (IVX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Invion Limited (IVX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Invion Limited (IVX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Invion Limited (IVX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$4 Notification regarding unquoted securities - IVX 12 Mar 2026 11:22AM $0.077 $0.035 fallen by 54.55%
$4 Section 708A Cleansing Statement 5 Mar 2026 12:48PM $0.079 $0.035 fallen by 55.70%
$4 Application for quotation of securities - IVX 5 Mar 2026 12:43PM $0.079 $0.035 fallen by 55.70%
$4 Cleansing Notice - Convertible Notes 5 Mar 2026 9:48AM $0.079 $0.035 fallen by 55.70%
$4 Notification regarding unquoted securities - IVX 5 Mar 2026 9:39AM $0.079 $0.035 fallen by 55.70%
$4 Appendix 4D and Half Year Financial Report 27 Feb 2026 9:32AM $0.081 $0.035 fallen by 56.79%
$4 Emergence 2026 Investor Presentation 19 Feb 2026 9:00AM $0.085 $0.035 fallen by 58.82%
$4 Notification regarding unquoted securities - IVX 19 Feb 2026 8:52AM $0.085 $0.035 fallen by 58.82%
$4 Appendix 4C and Quarterly Activities Report - December 2025 30 Jan 2026 6:18PM $0.092 $0.035 fallen by 61.96%
$4 Proposed issue of securities - IVX 30 Jan 2026 6:15PM $0.092 $0.035 fallen by 61.96%
$4 Proposed issue of securities - IVX 30 Jan 2026 6:14PM $0.092 $0.035 fallen by 61.96%
$4 Major Shareholders Lead Invion $1.3M Capital Raise 30 Jan 2026 6:14PM $0.092 $0.035 fallen by 61.96%
$4 Trading Halt 29 Jan 2026 10:00AM $0.092 $0.035 fallen by 61.96%
$4 Pause in Trading 29 Jan 2026 9:44AM $0.092 $0.035 fallen by 61.96%
$4 Notification of cessation of securities - IVX 13 Jan 2026 11:08AM $0.090 $0.035 fallen by 61.11%
$4 Hanlim & Korean Government Fund Pathway to Clinical Trial 23 Dec 2025 9:37AM $0.081 $0.035 fallen by 56.79%
$4 Invion Secures Expanded Photosoft Global Exclusive License 3 Dec 2025 8:43AM $0.079 $0.035 fallen by 55.70%
$4 Results of Annual General Meeting 26 Nov 2025 3:20PM $0.078 $0.035 fallen by 55.13%
$4 AGM Presentation 26 Nov 2025 12:33PM $0.078 $0.035 fallen by 55.13%
$4 Notification regarding unquoted securities - IVX 31 Oct 2025 1:09PM $0.093 $0.035 fallen by 62.37%
$4 Appendix 4C and Quarterly Activities Report - September 2025 31 Oct 2025 9:14AM $0.089 $0.035 fallen by 60.67%
$4 Notice of Annual General Meeting/Proxy Form 24 Oct 2025 9:06AM $0.092 $0.035 fallen by 61.96%
$4 Funded Collaboration Agreement with Protect Animal Health 21 Oct 2025 9:42AM $0.100 $0.035 fallen by 65%
$4 Proposed issue of securities - IVX 10 Oct 2025 10:06AM $0.100 $0.035 fallen by 65%
$4 Proposed issue of securities - IVX 10 Oct 2025 10:05AM $0.100 $0.035 fallen by 65%

26 - 50 of 711 results

Page 2 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.